Hemp, Inc. Announces a Mutual Letter of Intent to Sell a Non-Core
Business Division
LAS VEGAS, Oct. 2, 2013 /PRNewswire/ -- Hemp, Inc., (OTC:PK
HEMP) is pleased to announce it has completed a letter of intent to
sell the assets of its subsidiary, BioSwan, Inc., to BioAdaptives,
Inc. in an all-stock deal. It is expected to complete the
transaction over the next few weeks.
(Logo:
http://photos.prnewswire.com/prnh/20121107/LA08133LOGO)
Bruce Perlowin, CEO of Hemp, Inc.,
stated "The process of shedding non-core business and focusing on
our core hemp business while giving the shareholders of Hemp, Inc.
an opportunity for a great return has been much more time consuming
than originally anticipated. While we expected it to move more
quickly, we are now on track to complete the process and maintain
an extremely diverse set of opportunities for the shareholders in
Hemp, Inc."
David Tobias, President of Hemp,
Inc., went on to say "BioAdaptives, Inc. is a fully reporting
development stage company that is committed to the further
advancement of powerful stem cell enhancing nutraceuticals and
Hemp, Inc. retains the right to sell the products through its
Herbagenix division. It's the best of both worlds for Hemp, Inc.
which can now focus more effectively on hemp-based products while
maintaining diverse benefits for Hemp, Inc. shareholders."
Hemp, Inc.'s TRIPLE BOTTOM LINE
Hemp, Inc. (OTC:PK HEMP) seeks to benefit many constituencies,
not exploit or endanger any group of them. Thus, the
publicly-traded company believes in "upstreaming" of a portion of
profit from the marketing of their finished hemp goods back to its
originator. By Hemp, Inc. focusing on comprehensive investment
results—that is, with respect to performance along the interrelated
dimensions of people, planet, and profits— our triple bottom line
approach can be an important tool to support sustainability
goals.
CONTACT:
phone:1-877-221-8351
email: info@hemp.com
SOURCE Hemp, Inc.